Search by Drug Name or NDC
NDC 45802-0139-70 metronidazole vaginal 7.5 mg/g Details
metronidazole vaginal 7.5 mg/g
metronidazole vaginal is a VAGINAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is METRONIDAZOLE.
MedlinePlus Drug Summary
Metronidazole is used to treat vaginal infections such as bacterial vaginosis (an infection caused from too much of certain bacteria in the vagina). Metronidazole is in a class of medications called nitroimidazole antimicrobials. It works by stopping the growth of bacteria.
Related Packages: 45802-0139-70Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Metronidazole Vaginal
Product Information
| NDC | 45802-0139 |
|---|---|
| Product ID | 45802-139_ac51fedf-e650-40c6-a92f-d33d6f32e54b |
| Associated GPIs | 55100035004020 |
| GCN Sequence Number | 016939 |
| GCN Sequence Number Description | metronidazole GEL W/APPL 0.75 % VAGINAL |
| HIC3 | Q4W |
| HIC3 Description | VAGINAL ANTIBIOTICS |
| GCN | 49261 |
| HICL Sequence Number | 004157 |
| HICL Sequence Number Description | METRONIDAZOLE |
| Brand/Generic | Generic |
| Proprietary Name | metronidazole vaginal |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | metronidazole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | VAGINAL |
| Active Ingredient Strength | 7.5 |
| Active Ingredient Units | mg/g |
| Substance Name | METRONIDAZOLE |
| Labeler Name | Padagis Israel Pharmaceuticals Ltd |
| Pharmaceutical Class | Nitroimidazole Antimicrobial [EPC], Nitroimidazoles [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211786 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 45802-0139-70 (45802013970)
| NDC Package Code | 45802-139-70 |
|---|---|
| Billing NDC | 45802013970 |
| Package | 1 TUBE in 1 CARTON (45802-139-70) / 70 g in 1 TUBE |
| Marketing Start Date | 2019-07-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.3543 |
| Pricing Unit | GM |
| Effective Date | 2024-02-21 |
| NDC Description | METRONIDAZOLE VAGINAL 0.75% GL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis